Transcription of Cellular Therapies – Program Chairs: Baculovirus ...
{{id}} {{{paragraph}}}
Viral Vectors & Vaccines Program Chairs: Cellular Therapies Program Chairs: Baculovirus Expression Technology Program Chairs: Otto-Wilhelm Merten, PhD G n thon Martin A. Giedlin, PhD Novartis Pharmaceuticals Corporation Manuel Carrondo, PhD Instituto de Biologia Amine A. Kamen, PhD McGill University Gary K. Lee, PhD Sangamo BioSciences, Inc. Experimental e Tecnol gica (iBET). Clifton E. McPherson, PhD Protein Sciences Corporation, A Sanofi Company SUNDAY MARCH 4, 2018. 3:00 pm 7:00 pm Welcome Reception and Registration in the Granby Ballroom Foyer, Third Floor MONDAY MARCH 5, 2018. 7:00 am 8:00 am Registration and Breakfast in the Granby Ballroom Foyer, Third Floor 8:00 am 8:30 am Meeting Overview in Momentum, Third Floor Viral Vectors & Vaccines Cellular Therapies Baculovirus Expression Technology Momentum, Third Floor Fusion, Third Floor Energy, Third Floor View Speaker Abstracts & Bios View Speaker Abstracts & Bios View Speaker Abstracts & Bios 8:30 am 9:15 am OneBac rAAV Scale-Up Production Platform with Serotype-Specific Successful Manufacturing of T-Cell Therapies : Challenges and The Complete Genome Sequence of a Trichoplusia ni Cell Line, Modulation of AAV Capsid Protein Stoichiometry Opportunities Tni-FNL.
2 ISBioTech 8th Spring Meeting (continued): TUESDAY MARCH 6, 2018• Viral Vectors & Vaccines Momentum, Third Floor Cellular Therapies Fusion, Third Floor
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Continuous Flow Ultracentrifuge System for, Continuous Flow Ultracentrifuge System for Production, CENTIFUGES AND, Ultracentrifuge, ELECTROPHORESIS PROCEDURE HELENA, Sucrose Gradient Separation Protocol, Centrifugation, Gradient Appendix, Appendix, Of formaldehyde and binary ethyleneimine, Of formaldehyde and binary ethyleneimine BEI